Skip to main content
Log in

Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Y. Liel., M. Abu. Tailakh., Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting. Endocrine 63, 651–656 (2019)

    Article  CAS  PubMed  Google Scholar 

  2. A.A. Al. Nofal., O. Altayar., K. BenKhadra., O.Q. Qasim. Agha., N. Asi., M. Nabhan. et al. Bone turnover markers in Paget’s disease of the bone: a systematic review and meta-analysis. Osteoporos. Int. 26, 1875–1891 (2015)

    Article  CAS  PubMed  Google Scholar 

  3. D. Wolverton, D.P. Elliott, Evaluating the evidence behind treating osteoporosis in the oldest adults. Consult. Pharm. 33, 308–316 (2018)

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by grants from the National Natural Science Foundation of China [grant numbers 81471091 and 81870622] and the Hunan Natural Science Foundation [grant number 2018JJ2574].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-feng Sheng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All research procedures in this study were in accordance with the ethical standards of institutions and to the 1964 Helsinki declaration and its subsequent amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, S., Ou, Yn. & Sheng, Zf. Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting. Endocrine 65, 223–224 (2019). https://doi.org/10.1007/s12020-019-01966-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-01966-1

Navigation